Loss of TTC17 promotes breast cancer metastasis through RAP1/CDC42 signaling and sensitizes it to rapamycin and paclitaxel

Overview of attention for article published in Cell & Bioscience, March 2023

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 353 followers.

Loss of TTC17 promotes breast cancer metastasis through RAP1/CDC42 signaling and sensitizes it to rapamycin and paclitaxel https://t.co/3fwr6m7gOq

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.